Press Releases

Press Releases

    Date Title View
    09/16/22
    Summary ToggleHorizon Therapeutics plc Makes Founding Gift to Support the University of Notre Dame’s Patient Advocacy Initiative
    PDF Version
    09/14/22
    Summary ToggleData from the MIRROR Randomized Controlled Trial of KRYSTEXXA® (pegloticase) Injection with Methotrexate Published in Arthritis & Rheumatology
    PDF Version
    09/13/22
    Summary ToggleHorizon Therapeutics plc Joins the International Agency for the Prevention of Blindness (IAPB) to Encourage People to #LoveYourEyes this World Sight Day
    PDF Version
    09/12/22
    Summary ToggleHorizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint
    PDF Version
    09/09/22
    Summary ToggleHorizon Therapeutics plc Announces $500 Million Share Repurchase Program
    PDF Version
    09/08/22
    Summary ToggleHorizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2022 List
    PDF Version
    08/31/22
    Summary ToggleHorizon Therapeutics plc Named One of PEOPLE’s 100 Companies That Care®
    PDF Version
    08/29/22
    Summary ToggleHorizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland
    PDF Version
    08/25/22
    Summary ToggleHorizon Therapeutics plc to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
    PDF Version
    08/15/22
    Summary ToggleQ32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases
    PDF Version
    Displaying 21 - 30 of 701 results